Clinical Trials

50 enrolled 13 charts

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Salivary Gland Neoplasms

NCT03769467 2024-11-14

Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)

Phase 1/2 Terminated

12 enrolled 8 charts

BreastDermatologicGynecologicHead & NeckSarcomaThoracic

Nasopharyngeal Carcinoma, Carcinoma, Head and Neck Neoplasms, Stomatognathic Diseases, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Nose Neoplasms, Otorhinolaryngologic Diseases, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Pharyngeal Neoplasms, Epstein-Barr Virus Infections

NCT05955105 2024-05-21

A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

Phase 1/2 Recruiting

200 enrolled

Nasopharyngeal Carcinoma, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT03682055 2023-08-15

Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC)

Phase 1/2 Terminated

14 enrolled 13 charts

Phase 1/2 Not yet recruiting

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

NCT05898256 2023-06-12

Cadonilimab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma

20 enrolled

Nasopharyngeal Carcinoma

NCT05341193 2022-04-22

PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma

32 enrolled

Nasopharyngeal Carcinoma

NCT02915432 2021-12-13

The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC

GastrointestinalHead & Neck

401 enrolled 1 FDA

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Esophageal Squamous Cell Carcinoma

NCT02801487 2020-02-17

Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma

Phase 1/2 Terminated

6 enrolled

Nasopharyngeal Carcinoma

NCT03701451 2018-10-10

Demethylated Drug in the Treatment of Nasopharyngeal Carcinoma

30 enrolled

Nasopharyngeal Carcinoma

NCT03639467 2018-09-18

Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma

40 enrolled

Nasopharyngeal Carcinoma

NCT01534585 2018-04-17

Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma

48 enrolled

Nasopharyngeal Carcinoma

NCT03044743 2017-05-02

PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies

GastrointestinalHead & NeckLymphoid

20 enrolled

Nasopharyngeal Carcinoma, Hodgkin Disease, Stomach Neoplasms, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

NCT03047525 2017-02-09

Study of DC-CTL Combined With CIK for Advanced Solid Tumor

GastrointestinalGenitourinaryHead & NeckThoracic

200 enrolled

Nasopharyngeal Carcinoma, Carcinoma, Renal Cell, Lung Neoplasms, Colorectal Neoplasms

NCT02980315 2016-12-02

A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application

20 enrolled

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT02523430 2016-07-19

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal Carcinoma

60 enrolled

Nasopharyngeal Carcinoma

NCT01712919 2014-03-24

Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC)

61 enrolled

Nasopharyngeal Carcinoma

NCT00212108 2012-04-02

A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839

22 enrolled

Nasopharyngeal Carcinoma

NCT01449942 2011-10-10

NPC-DZ

40 enrolled